TipRanks
Advertisement
Advertisement

APLIF Stock Latest News

Appili Therapeutics to Delist from TSX and Move Listing to NEX
Company AnnouncementsAppili Therapeutics to Delist from TSX and Move Listing to NEX
12d ago
Appili Therapeutics Targets New Funding and Partnerships at World Vaccine Congress Washington
PremiumCompany Announcements
Appili Therapeutics Targets New Funding and Partnerships at World Vaccine Congress Washington
7M ago
Appili Therapeutics Raises C$100,000 in Second Tranche of Private Placement
PremiumCompany Announcements
Appili Therapeutics Raises C$100,000 in Second Tranche of Private Placement
8M ago
Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances
PremiumCompany Announcements
Appili Deepens Non-Dilutive Funding Base as Infectious Disease Pipeline Advances
8M ago
Appili Therapeutics Raises C$177,500 in First Tranche of Private Placement
PremiumCompany Announcements
Appili Therapeutics Raises C$177,500 in First Tranche of Private Placement
10M ago
Appili Therapeutics Reports Strong Q2 Results and Secures Major Funding for Infectious Disease Programs
PremiumCompany AnnouncementsAppili Therapeutics Reports Strong Q2 Results and Secures Major Funding for Infectious Disease Programs
11M ago
Appili Therapeutics Launches C$750,000 Private Placement to Boost Drug Development
Premium
Company Announcements
Appili Therapeutics Launches C$750,000 Private Placement to Boost Drug Development
11M ago
Appili Therapeutics prices 30M units at $0.025 in private placement
Premium
The Fly
Appili Therapeutics prices 30M units at $0.025 in private placement
11M ago
Appili Therapeutics to Showcase Biodefense Innovations at BARDA Symposium
PremiumCompany Announcements
Appili Therapeutics to Showcase Biodefense Innovations at BARDA Symposium
12M ago
Appili Therapeutics Secures $40 Million Contract for Fungal Vaccine Development
PremiumCompany Announcements
Appili Therapeutics Secures $40 Million Contract for Fungal Vaccine Development
1y ago
Appili Therapeutics, Vitalix awarded up to $40M contract from NIAID
PremiumThe Fly
Appili Therapeutics, Vitalix awarded up to $40M contract from NIAID
1y ago
Appili Therapeutics Secures Shareholder Approval for Strategic Initiatives
PremiumCompany Announcements
Appili Therapeutics Secures Shareholder Approval for Strategic Initiatives
1y ago
Appili Therapeutics to Showcase Tularemia Vaccine at NATO Conference
PremiumCompany AnnouncementsAppili Therapeutics to Showcase Tularemia Vaccine at NATO Conference
1y ago
Appili Therapeutics to present progress on Tularemia vaccine
Premium
The Fly
Appili Therapeutics to present progress on Tularemia vaccine
1y ago
Appili Therapeutics Strengthens Biodefense Partnerships and Advances Drug Development
Premium
Company Announcements
Appili Therapeutics Strengthens Biodefense Partnerships and Advances Drug Development
1y ago
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
PremiumThe Fly
Appili Therapeutics, colleagues publish manuscript on ATI-1701 efficacy
1y ago
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
PremiumCompany Announcements
Appili Therapeutics Demonstrates Efficacy of Tularemia Vaccine Candidate
1y ago
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
PremiumCompany Announcements
Appili Therapeutics Advances Infectious Disease Solutions with LIKMEZ Re-launch and Vaccine Developments
1y ago
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
PremiumCompany Announcements
Appili Therapeutics Ends Agreement with Aditxt, Secures Loan Extensions
1y ago
Appili Therapeutics Faces Termination of Agreement with Aditxt
PremiumCompany AnnouncementsAppili Therapeutics Faces Termination of Agreement with Aditxt
1y ago
Aditxt announces termination of arrangement agreement with Appili Therapeutics
Premium
The Fly
Aditxt announces termination of arrangement agreement with Appili Therapeutics
1y ago
ADTX
Appili Therapeutics Advances Tularemia Vaccine Research
Premium
Company Announcements
Appili Therapeutics Advances Tularemia Vaccine Research
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >